Government Should Experiment with Eliminating Patient Barriers, Not with Covering Ozempic

Akiva Malamet, Bautista Vivanco, and Michael F. Cannon

The Trump administration is planning to expand Medicare and Medicaid coverage of expensive weight-loss drugs like Ozempic under a five-year experiment, according to documents the